We showed that KYNU was enzymatically functional in LUAD cells and that elevated tumoral KYNU was profoundly associated with an immunosuppressive tumor microenvironment, characterized by increased regulatory T-cells and increased expression of immune checkpoint blockade targets including PD-L1. This evidence concerns the gene CD274 and neoplasm.